Disruption of VEGF-A signaling in mice was found to reduce fenestration and lipoprotein uptake23, whereas controlled overexpression of this growth factor was reported to reduce hepatic steatosis and extend the life-span of mice73. Here, VEGFA is linked to fatty liver disease.